Quick Answer
Cardiff Oncology, Inc. reported Shares Outstanding of 68.31 million shares for fiscal year 2025.
Cardiff Oncology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 68.31M | +2.7% |
| 2024 | 66.52M | +48.9% |
| 2023 | 44.68M | +0.0% |
| 2022 | 44.68M | +6.5% |
| 2021 | 41.96M | +14.1% |
| 2020 | 36.78M | +328.0% |
| 2019 | 8.59M | +124.3% |
| 2018 | 3.83M | +422.6% |
| 2017 | 733,217 | -97.6% |
| 2016 | 30.70M | +3.2% |
| 2015 | 29.74M | +57.2% |
| 2014 | 18.92M | +0.1% |
| 2013 | 18.90M | +22.1% |
| 2012 | 15.48M | +44.2% |
| 2011 | 10.74M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 67.09M | +37.7% | +0.9% |
| June 30, 2025 | 66.53M | +45.9% | +0.0% |
| March 31, 2025 | 66.53M | +48.8% | +0.0% |
| December 31, 2024 | 66.52M | +48.9% | +36.5% |
| September 30, 2024 | 48.73M | +9.1% | +6.9% |
| June 30, 2024 | 45.60M | +2.1% | +2.0% |
| March 31, 2024 | 44.71M | +0.1% | +0.1% |
| December 31, 2023 | 44.68M | +0.0% | +0.0% |
- Cardiff Oncology, Inc. showed an increase of +2.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Cardiff Oncology, Inc.’s shares outstanding has grown by 536.2% (from 10.74 million shares to 68.31 million shares).
- The most recent figure is from Cardiff Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: